The review, published in Journal of Osteopathic Medicine, found that scent dogs are as effective, or even more effective, and could be a key tool in future pandemics, a new review of recent research suggests.
“Although many people have heard about the exceptional abilities of dogs to help humans, their value to the medical field has been considered fascinating, but not ready for real-world medical use,” said Prof. Tommy Dickey from the University of California, Santa Barbara in the US.
“Having conducted this review, we believe that scent dogs deserve their place as a serious diagnostic methodology that could be particularly useful during pandemics, potentially as part of rapid health screenings in public spaces. We are confident that scent dogs will be useful in detecting a wide variety of diseases in the future,” he added.
In the study, researchers reviewed 29 studies where dogs were used to detect Covid-19.
The studies were performed using over 31,000 samples by over 400 scientists from more than 30 countries using 19 different dog breeds.
In some studies, the scent dogs sniffed people directly, sometimes in public places as a health screening.
In others, the dogs sniffed patient samples such as sweat, saliva or urine samples.
In the majority of studies, the scent dogs demonstrated similar or better sensitivity and specificity than the current gold-standard RT-PCR tests or antigen tests.
In one study, four of the dogs could detect the equivalent of less than 2.6 x 10-12 copies of viral RNA per millilitre.
This is equivalent to detecting one drop of any odorous substance dissolved in ten and a half Olympic-sized swimming pools and is three orders of magnitude better than modern scientific instruments.
The dogs could detect Covid-19 in symptomatic, pre-symptomatic and asymptomatic patients, along with new Covid variants and even long Covid.
A major benefit of using the dogs was their speed — they could provide a result in seconds to minutes, and did not require expensive lab equipment or create mountains of plastic waste, unlike conventional diagnostic approaches.
Dogs possess up to 300 million olfactory cells, compared to just 5 or 6 million in humans, and use one-third of their brains to process scent information, compared with just 5 per cent for humans.
Dogs trained to recognise specific volatile organic compounds created in the body during disease have successfully identified patients with certain cancers, Parkinson’s and diabetes.
–IANS
rvt/pgh
